Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: A&G PHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-24 to 2020-06-30
Current total value of award: $50208.55
Description: GENERATING DRUG SPECIFIC MONOCLONAL ANTIBODIES AGAINST TTHX1114, AN ENGINEERED MUTANT HUMAN FGF1: GENERATING DRUG SPECIFIC MONOCLONAL ANTIBODIES AGAINST TTHX1114, AN ENGINEERED MUTANT HUMAN FGF1, TASK ORDER NO. 1 UNDER THE PARENT IDIQ, REAGENT GENERA